On this page
What each program costs in Iowa
The monthly price is all-in: the drug plus a membership when we have verified one. Compounded drugs are not FDA-approved.
| # | Program | Cheapest product | Plan | All in | Membership fee | Trustpilot | Checked | Seller site |
|---|---|---|---|---|---|---|---|---|
| 1 | Compounded Semaglutide | sale price | $39/mo | not verified | too few reviews | Visit | ||
| 2 | Compounded Semaglutide | 12-month plan, $588 up front | $49/mo | none | 3.9 (11,798 reviews) | Visit | ||
| 3 | Compounded Semaglutide | month to month | $59/mo | none | too few reviews | Visit | ||
| 4 | Compounded Semaglutide | 12-month plan, $828 up front | $69/mo | none | 4.6 (4,268 reviews) | Visit | ||
| 5 | Compounded Semaglutide | medication monthly, membership yearly | $75/mo | $199/yr, included | 4.8 (288 reviews) | Visit | ||
| 6 | Compounded Semaglutide | month to month | $79/mo | none | too few reviews | Visit | ||
| 7 | Compounded Semaglutide | month to month | $99/mo | none | 4.6 (5,235 reviews) | Visit | ||
| 8 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.3 (880 reviews) | Visit | ||
| 9 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.2 (218 reviews) | Visit | ||
| 10 | Compounded Semaglutide | 12-month plan, $1,260 up front | $105/mo | none | too few reviews | Visit | ||
| 11 | Compounded Semaglutide | 12-month plan, $1,698 up front | $141/mo | none | too few reviews | Visit | ||
| 12 | Semaglutide | month to month | $149/mo | none | too few reviews | Visit | ||
| 13 | Compounded Semaglutide | 12-month plan, $1,788 up front | $149/mo | none | 4.2 (777 reviews) | Visit | ||
| 14 | Microdosing Tirzepatide | 12-month plan, $2,028 up front | $169/mo | none | 4.0 (162 reviews) | Visit | ||
| 15 | Compounded Semaglutide | 2-month plan, $350 up front | $175/mo | none | 4.6 (1,084 reviews) | Visit | ||
| 16 | Compounded Oral Semaglutide Capsules | 6-month plan, $1,194 up front | $199/mo | none | too few reviews | Visit | ||
| 17 | Foundayo (brand orforglipron) | medication monthly, membership yearly | $208/mo | $59/mo, billed yearly, included | 4.6 (4,607 reviews) | Visit | ||
| 18 | Sublingual Semaglutide | month to month | $249/mo | none | 4.5 (17,622 reviews) | Visit | ||
| 19 | Compounded Semaglutide | month to month | $299/mo | none | too few reviews | Visit |
Does the State of Iowa employee PPO plan (Wellmark) cover GLP-1s for weight loss?
The coverage manual for the State of Iowa's National Choice active employee PPO, effective January 1, 2026 and administered by Wellmark, lists weight reduction drugs among the drugs excluded from the pharmacy benefit.
Does Iowa Medicaid cover GLP-1s for weight loss?
Not covered for weight loss
Iowa Medicaid's rules exclude drugs used for weight loss and its October 2026 criteria deny payment for that use, so it does not cover Wegovy or Zepbound for weight loss. Read from state documents Nov 6, 2026.
What Iowa Medicaid's documents say about each drug for weight loss. Read Nov 6, 2026. Iowa Department of Health and Human Services, Iowa Medicaid.
WegovyNo
Prior authorization for heart risk in adults with established heart disease and BMI 27 or higher, or for the liver condition MASH.
“Payment for excluded medical use(s) (e.g. weight loss), as defined in the Iowa State Plan and Iowa Administrative Code”
Iowa Medicaid (Iowa HHS, PDL site run by Optum Rx) · Effective Oct 1, 2026 · read Nov 6, 2026
“Drugs used for anorexia, weight gain, or weight loss.”
Iowa Administrative Code 441-78.2 · No effective date on the document · read Nov 6, 2026
“The requested drug will be used to reduce the risk of major adverse cardiovascular events (MACE)”
Iowa Medicaid (Iowa HHS, PDL site run by Optum Rx) · No effective date on the document · read Nov 6, 2026
ZepboundNo
Prior authorization for moderate to severe sleep apnea with BMI 30 or higher.
“Payment for excluded medical use(s) (e.g. weight loss), as defined in the Iowa State Plan and Iowa Administrative Code”
Iowa Medicaid (Iowa HHS, PDL site run by Optum Rx) · Effective Oct 1, 2026 · read Nov 6, 2026
“Drugs used for anorexia, weight gain, or weight loss.”
Iowa Administrative Code 441-78.2 · No effective date on the document · read Nov 6, 2026
“Patient has a diagnosis of moderate to severe obstructive sleep apnea (OSA); and”
Iowa Medicaid (Iowa HHS, PDL site run by Optum Rx) · No effective date on the document · read Nov 6, 2026
OzempicNo
Listed on the diabetes drug form with prior authorization. That form denies requests for weight loss.
“Requests for weight loss, which is not a covered diagnosis of use, will be denied.”
Iowa Medicaid (Iowa HHS, PDL site run by Optum Rx) · No effective date on the document · read Nov 6, 2026
“Drugs used for anorexia, weight gain, or weight loss.”
Iowa Administrative Code 441-78.2 · No effective date on the document · read Nov 6, 2026
MounjaroNo
Listed on the diabetes drug form with prior authorization. That form denies requests for weight loss.
“Requests for weight loss, which is not a covered diagnosis of use, will be denied.”
Iowa Medicaid (Iowa HHS, PDL site run by Optum Rx) · No effective date on the document · read Nov 6, 2026
“Drugs used for anorexia, weight gain, or weight loss.”
Iowa Administrative Code 441-78.2 · No effective date on the document · read Nov 6, 2026
This reports what the documents say. It is not medical or legal advice: your plan and your prescriber decide.
What changed, and when
- Nov 6, 2026 · This pageFirst read from Iowa Department of Health and Human Services, Iowa Medicaid documents. KFF's January 2026 map listed this program as not covered; the documents we read agree.
Weight loss
Not covered, read Nov 2026
Type 2 diabetes
Required in every state
Heart risk, sleep apnea
Required (Wegovy, Zepbound)
Prior authorization
Typical when covered
Wegovy, Zepbound, Saxenda, 2025
6,083 prescriptions
Ozempic and Mounjaro, 2025
69,195 prescriptions
Neighbours covering weight loss
3 of 6
Federal law lets each state decide whether Medicaid pays for drugs used for weight loss, while drugs approved for diabetes must be covered. A state document may not settle every plan; if your Iowa Medicaid coverage comes through a managed care plan, its formulary can differ, so ask the plan before you fill.
For comparison, a dated secondary source: KFF's January 2026 map listed Iowa Medicaid as "not covered" for GLP-1s for obesity under fee-for-service.
The BALANCE model
CMS’s BALANCE model lets state Medicaid programs add GLP-1s for weight management at a negotiated price. States could join on a rolling basis from May 1, 2026 through January 1, 2027, and the state application deadline was July 31, 2026. We could not find a published list of the states that joined, so this page does not say whether Iowa Medicaid did. Ask your plan. Either way your cost stays at Medicaid’s nominal copay, which BALANCE does not change.
The national picture, coupons and patient assistance: does Medicaid cover GLP-1s.
How many GLP-1s does Iowa Medicaid pay for?
88,518 GLP-1 prescriptions in 2025, 26th of the 50 states and DC, with $87.4 million reimbursed before rebates. Counting the share other payers covered, $87.4 million.
Prescriptions, 2025
88,518
26th of 51
Medicaid paid
$87.4M
25th of 51, before rebates
Per prescription
$987
$1,051 nationally
Weight-loss brands
6.9%
19th highest share of 51
CMS State Drug Utilization Data 2025, updated Jul 13, 2026, fee-for-service and managed care, before rebates. Iowa is highlighted. CMS publishes this comparison as one year, not a trend.
Wegovy, Zepbound and Saxenda, the brands approved for weight management, were 6.9% of Iowa Medicaid's GLP-1 prescriptions in 2025 (6,083). Across the 13 states KFF lists as covering GLP-1s for obesity, the median share was 52%; across the other 38, 2.3%. Where weight loss is not covered, those brands are mostly filled for the uses Medicaid must cover, such as heart risk and sleep apnea. Ozempic was Iowa Medicaid's most filled GLP-1.
| Brand | Prescriptions | Share | Medicaid paid | Per Rx |
|---|---|---|---|---|
| Ozempic | 51,808 | 59% | $50.1 million | $968 |
| Mounjaro | 17,387 | 20% | $18.2 million | $1,046 |
| Trulicity | 11,698 | 13% | $11.1 million | $952 |
| Zepboundapproved for weight management | 5,112 | 5.8% | $5.4 million | $1,061 |
| Wegovyapproved for weight management | 971 | 1.1% | $1.3 million | $1,327 |
| Rybelsus | 866 | 1.0% | $850,730 | $982 |
| Liraglutide (generic) | 548 | 0.6% | $263,038 | $480 |
| Victoza | 112 | 0.1% | $68,443 | $611 |
| Bydureon | 16 | 0.0% | $12,747 | $797 |
Source: CMS State Drug Utilization Data 2025, updated Jul 13, 2026, all four quarters, fee-for-service and managed care. Before rebates. CMS suppresses rows under 11 prescriptions, so small brands are undercounted slightly. Every state ranked: prescriptions and spending.
On Medicare in Iowa?
Medicare’s temporary GLP-1 Bridge works the same in every state: a $50 copay for a one-month supply of Wegovy, Foundayo or the Zepbound KwikPen, for people with Part D who meet its weight and health rules.
medicare.gov
“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”
https://www.medicare.gov/coverage/weight-loss-drugs · read Nov 14, 2026
Iowa and the states around it
Medicaid’s weight-loss answer (the state’s own documents where we have read them, otherwise KFF, January 2026) and the partner programs that ship there, priced the same way as above.
3 of the 6 states next to Iowa cover GLP-1s for weight loss through Medicaid: Minnesota, Missouri and Wisconsin. None has a lower cash floor than Iowa's $39.
| State | Medicaid, weight loss | Ship there | Cheapest that ships there |
|---|---|---|---|
| Iowa | Not covered | 19 | $39/mo |
| Illinois | Not covered | 19 | $39/moWellmedr |
| Minnesota | Covered | 19 | $39/moWellmedr |
| Missouri | Zepbound only | 18 | $39/moWellmedr |
| Nebraska | Not covered | 19 | $39/moWellmedr |
| South Dakota | Not covered | 19 | $39/moWellmedr |
| Wisconsin | Zepbound only | 19 | $39/moWellmedr |






















